Menu

Interpace Biosciences, Inc. IDXG

Full chart Compare
Set alert

Price alert · IDXG

All alert types
6.60 USD -0.40 (-5.71%)

At closeNov 11, 2026, 4:00 PM EST

6.20 Day range 6.60
0.83 52-week range 7.62
YTD
+436.59%
1 year
+489.29%

Revenue & Expenses

Income Tax Benefit → Gross Profit & Other Income: $21.21MGross Profit & Other Income → Net Income: $24.57MGross Profit & Other Income → Selling, General & Admin: $19.40MGross Profit & Other Income → Research & Development: $642.00KGross Profit & Other Income → Interest Expense: $168.00KGross Profit & Other Income → Other Expenses: $551.00KGross Profit → Gross Profit & Other Income: $24.13MRevenue → Gross Profit: $24.13MRevenue → Cost of Revenue: $14.60MIncome Tax Benefit$21.21MGross Profit$24.13MCost of Revenue$14.60MGross Profit & Other Income$45.34MNet Income$24.57MSelling, General & Admin$19.40MResearch & Development$642.00KInterest Expense$168.00KOther Expenses$551.00KRevenue$38.73M

Latest period ending Dec 31, 2022 · select a line to chart its full history

Annual income statement

IDXG annual income statement
Fiscal yearFY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020FY 2019 Dec 31, 2019FY 2018 Dec 31, 2018
31.84M33.12M32.40M24.22M21.90M
31.84M33.12M32.40M24.22M21.90M
13.61M14.31M21.67M15.89M10.20M
18.23M18.80M10.72M8.33M11.70M
22.07M25.48M37.28M34.81M22.81M
703.00K1.49M2.79M2.81M2.12M
20.10M19.88M27.45M25.48M17.10M
-3.84M-6.67M-26.55M-26.48M-11.11M
1.01M1.04M549.00K440.00K331.00K
29.00K-705.00K53.00K-28.00K18.00K
-21.96M-14.94M-26.45M-26.74M-12.70M
-21.96M-14.94M-29.48M-27.17M-12.70M
-21.96M-14.94M-29.48M-27.17M-12.70M
-21.96M-14.94M-26.45M-26.74M-12.70M
16.09M7.91M250.00K88.00K-16.00K
-5.18-3.61-7.32-7.25-4.52
-5.18-3.61-7.32-7.25-4.52
-5.18-3.61-7.32-7.25-4.52
-20.92M-14.61M-25.85M-26.33M-12.35M
-20.92M-14.61M-25.85M-26.33M-12.35M
4.24M4.13M4.03M3.75M2.82M
4.24M4.13M4.03M3.75M2.82M